Cite Filings / ROIV / 0001950047-26-011011
Feed Companies Filings Check
Sign in
144

Sale of Securities

Roivant Sciences Ltd. · Filed 2026-11-12 · Acc 0001950047-26-011011

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-11-12 144 Sale of Securities
  • 2026-11-12 4 President and Vant Chair disposed of 1,176,143 shares (other)
  • 2026-11-12 4 CEO disposed of 156,307 shares (other)
  • 2026-11-12 4 President & CIO disposed of 165,444 shares (other)
  • 2026-11-12 4 CFO sold 300,000 shares at an average $41.58 ($12,473,272)
  • 2026-11-12 4 President & Immunovant CEO sold 187,943 shares at an average $40.53 ($7,617,074)
  • 2026-11-10 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…